Logo image of CAAS

CHINA AUTOMOTIVE SYSTEMS INC (CAAS) Stock Fundamental Analysis

NASDAQ:CAAS - US16936R1059 - Common Stock

4.44 USD
-0.02 (-0.45%)
Last: 9/5/2025, 8:01:02 PM
Fundamental Rating

3

Overall CAAS gets a fundamental rating of 3 out of 10. We evaluated CAAS against 80 industry peers in the Automobile Components industry. While CAAS is still in line with the averages on profitability rating, there are concerns on its financial health. CAAS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CAAS was profitable.
CAAS had a positive operating cash flow in the past year.
CAAS had positive earnings in 4 of the past 5 years.
CAAS had a positive operating cash flow in each of the past 5 years.
CAAS Yearly Net Income VS EBIT VS OCF VS FCFCAAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.47%, CAAS is doing worse than 62.50% of the companies in the same industry.
CAAS has a Return On Equity of 8.00%. This is in the lower half of the industry: CAAS underperforms 63.75% of its industry peers.
The Return On Invested Capital of CAAS (5.82%) is worse than 71.25% of its industry peers.
CAAS had an Average Return On Invested Capital over the past 3 years of 4.01%. This is below the industry average of 8.51%.
The 3 year average ROIC (4.01%) for CAAS is below the current ROIC(5.82%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.47%
ROE 8%
ROIC 5.82%
ROA(3y)3.8%
ROA(5y)2.45%
ROE(3y)8.77%
ROE(5y)5.62%
ROIC(3y)4.01%
ROIC(5y)N/A
CAAS Yearly ROA, ROE, ROICCAAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

CAAS has a Profit Margin of 4.21%. This is comparable to the rest of the industry: CAAS outperforms 42.50% of its industry peers.
CAAS's Profit Margin has improved in the last couple of years.
The Operating Margin of CAAS (5.42%) is worse than 67.50% of its industry peers.
CAAS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 16.51%, CAAS is doing worse than 80.00% of the companies in the same industry.
CAAS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.42%
PM (TTM) 4.21%
GM 16.51%
OM growth 3Y184.06%
OM growth 5Y84.98%
PM growth 3Y27.37%
PM growth 5Y14.72%
GM growth 3Y5.03%
GM growth 5Y2.68%
CAAS Yearly Profit, Operating, Gross MarginsCAAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAAS is destroying value.
Compared to 1 year ago, CAAS has about the same amount of shares outstanding.
Compared to 5 years ago, CAAS has less shares outstanding
Compared to 1 year ago, CAAS has a worse debt to assets ratio.
CAAS Yearly Shares OutstandingCAAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CAAS Yearly Total Debt VS Total AssetsCAAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CAAS has an Altman-Z score of 1.91. This is not the best score and indicates that CAAS is in the grey zone with still only limited risk for bankruptcy at the moment.
CAAS has a Altman-Z score of 1.91. This is in the lower half of the industry: CAAS underperforms 76.25% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that CAAS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.43, CAAS is not doing good in the industry: 67.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC0.84
WACC6.97%
CAAS Yearly LT Debt VS Equity VS FCFCAAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CAAS has a Current Ratio of 1.40. This is a normal value and indicates that CAAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.40, CAAS is doing worse than 83.75% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that CAAS should not have too much problems paying its short term obligations.
CAAS has a Quick ratio of 1.13. This is in the better half of the industry: CAAS outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.13
CAAS Yearly Current Assets VS Current LiabilitesCAAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for CAAS have decreased strongly by -17.80% in the last year.
Measured over the past years, CAAS shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.34% on average per year.
CAAS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.09%.
CAAS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.58% yearly.
EPS 1Y (TTM)-17.8%
EPS 3Y41.42%
EPS 5Y25.34%
EPS Q2Q%4.17%
Revenue 1Y (TTM)17.09%
Revenue growth 3Y9.34%
Revenue growth 5Y8.58%
Sales Q2Q%11.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAAS Yearly Revenue VS EstimatesCAAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CAAS Yearly EPS VS EstimatesCAAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.2 0.4 0.6 0.8 1

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.58, the valuation of CAAS can be described as very cheap.
Based on the Price/Earnings ratio, CAAS is valued cheaply inside the industry as 98.75% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CAAS to the average of the S&P500 Index (27.06), we can say CAAS is valued rather cheaply.
Industry RankSector Rank
PE 4.58
Fwd PE N/A
CAAS Price Earnings VS Forward Price EarningsCAAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CAAS is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.58
CAAS Per share dataCAAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CAAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHINA AUTOMOTIVE SYSTEMS INC

NASDAQ:CAAS (9/5/2025, 8:01:02 PM)

4.44

-0.02 (-0.45%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners4.37%
Inst Owner Change0.18%
Ins Owners61.52%
Ins Owner Change0%
Market Cap133.95M
Analysts82.86
Price TargetN/A
Short Float %0.38%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.74
Dividend Growth(5Y)N/A
DP82.56%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.58
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF 2.69
P/B 0.37
P/tB 0.37
EV/EBITDA 0.58
EPS(TTM)0.97
EY21.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)1.65
OCFY37.12%
SpS23.08
BVpS12.14
TBVpS12.14
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 3.47%
ROE 8%
ROCE 9.1%
ROIC 5.82%
ROICexc 7.09%
ROICexgc 7.09%
OM 5.42%
PM (TTM) 4.21%
GM 16.51%
FCFM N/A
ROA(3y)3.8%
ROA(5y)2.45%
ROE(3y)8.77%
ROE(5y)5.62%
ROIC(3y)4.01%
ROIC(5y)N/A
ROICexc(3y)5.04%
ROICexc(5y)N/A
ROICexgc(3y)5.08%
ROICexgc(5y)N/A
ROCE(3y)6.36%
ROCE(5y)N/A
ROICexcg growth 3Y183.23%
ROICexcg growth 5Y93.06%
ROICexc growth 3Y183.02%
ROICexc growth 5Y92.92%
OM growth 3Y184.06%
OM growth 5Y84.98%
PM growth 3Y27.37%
PM growth 5Y14.72%
GM growth 3Y5.03%
GM growth 5Y2.68%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 2.76
Cap/Depr 282.79%
Cap/Sales 7.56%
Interest Coverage 250
Cash Conversion 88.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.13
Altman-Z 1.91
F-Score5
WACC6.97%
ROIC/WACC0.84
Cap/Depr(3y)139.03%
Cap/Depr(5y)105.74%
Cap/Sales(3y)4.82%
Cap/Sales(5y)4.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.8%
EPS 3Y41.42%
EPS 5Y25.34%
EPS Q2Q%4.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.09%
Revenue growth 3Y9.34%
Revenue growth 5Y8.58%
Sales Q2Q%11.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.48%
EBIT growth 3Y210.59%
EBIT growth 5Y100.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-122.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.48%
OCF growth 3Y-29.81%
OCF growth 5Y-20.25%